Clinical Trial Update: The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) [Phase 4]

View source ↗

Summary

A phase 4 clinical trial assessing the impact of urate-lowering therapy on kidney function in patients with gout and chronic kidney disease (CKD) stages 1-4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Gout

Snippet

Sponsor: Medical Practice Prof D. Ivanov | Conditions: Gout, CKD Stage 1-4 | Phase 4 | Status: UNKNOWN